Clinical trial
Fabry Disease Registry & Pregnancy Sub-registry
NCT00196742 · Genzyme, a Sanofi Company, Industry · Recruiting
Key facts
| NCT number | NCT00196742 |
|---|---|
| Title | Fabry Disease Registry & Pregnancy Sub-registry |
| Official title | Fabry Disease Registry Protocol |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Recruiting |
| Study type | Observational [Patient Registry] |
| Conditions | Fabry Disease |
| Enrollment | 9,000 |
| Start date | Jul 31, 2001 |
| Primary completion | Jan 31, 2034 |
| Completion | Jan 31, 2034 |
| First posted | Sep 20, 2005 |
| Last update posted | Feb 13, 2026 |
| Countries | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark and 32 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: